Lomitapide Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 5 mg, 10 mg, 20 mg, 30 mg
Reference Brands: Juxtapid(USA), Lojuxta(EU)
Category: Heart Disorder
Lomitapide is a microsomal triglyceride transfer protein (MTP) inhibitor used to lower LDL cholesterol in adults with homozygous familial hypercholesterolemia (HoFH). It decreases lipoprotein assembly in the liver, leading to reduced LDL, total cholesterol, and non-HDL cholesterol. Lomitapide is available in Capsules and strengths such as 5 mg, 10 mg, 20 mg, 30 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Lomitapide is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Lomitapide can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Lomitapide is used to treat homozygous familial hypercholesterolemia (HoFH), a rare genetic disorder that causes extremely high cholesterol levels. It works by reducing the production of very low-density lipoprotein (VLDL) in the liver, thereby lowering LDL cholesterol levels.
It is made from the active ingredient lomitapide, an oral microsomal triglyceride transfer protein (MTP) inhibitor that interferes with lipid assembly and secretion in the liver and intestines.
The trade name is Juxtapid in the USA and Lojuxta in the EU.
It is manufactured by Aegerion Pharmaceuticals, which is a subsidiary of Amryt Pharma.
The generic name is Lomitapide.
Brand names include Juxtapid (USA) and Lojuxta (EU).
It is manufactured in approved pharmaceutical facilities by Aegerion/Amryt Pharma for global distribution.
Related Products
Dronedarone Hydrochloride
Strength:
400 mg
Form: Tablets
Reference Brands: Multaq (USA/EU)
View Details
Milrinone Lactate
Strength:
1 mg/ml, 5mg/ml
Form: Injection
Reference Brands: Primacor (USA/EU)
View Details
Midodrine Hydrochloride
Strength:
2.5 mg, 5 mg, 10 mg
Form: Tablets
Reference Brands: ProAmatine (USA/EU)
View Details
Mexiletine Hydrochloride
Strength:
100 mg, 200mg
Form: Capsules
Reference Brands: Mexitil (USA/EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
